Simon N.R. Harford
CIK 1443705 · Chief Financial Officer · last filed 2026-04-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
4
Total Filings
38
Lifetime Open-Market Net
-$138.7K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Chief Financial Officer | 0 | $14.49 | $0 | $0 | 7 | 2026-04-27 |
| ALBIREO PHARMA, INC. (ALBO) Delisted | CFO and Treasurer | 0 | $44.15 | $0 | -$138.7K | 27 | 2023-03-02 |
| PAREXEL INTERNATIONAL CORP (PRXL) Delisted | SVP & Chief Financial Officer | 10,736 | — | — | $0 | 1 | 2017-05-10 |
| AVON PRODUCTS INC (AVP) Delisted | Grp. VP & Corp. Controller | — | — | — | $0 | 2 | 2009-03-09 |
Recent Filings · Page 2 of 4
38 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-01-23 | ALBIREO PHARMA, INC. (ALBO) Delisted | Sell (S) | −102 | -$4.5K | EDGAR |
| 2023-01-20 | ALBIREO PHARMA, INC. (ALBO) Delisted | Sell (S) | −1,776 | -$77.8K | EDGAR |
| 2022-10-25 | ALBIREO PHARMA, INC. (ALBO) Delisted | Sell (S) | −104 | -$2.0K | EDGAR |
| 2022-10-13 | ALBIREO PHARMA, INC. (ALBO) Delisted | Sell (S) | −80 | -$1.9K | EDGAR |
| 2022-07-25 | ALBIREO PHARMA, INC. (ALBO) Delisted | Sell (S) | −106 | -$2.6K | EDGAR |
| 2022-07-13 | ALBIREO PHARMA, INC. (ALBO) Delisted | Sell (S) | −95 | -$2.3K | EDGAR |
| 2022-04-25 | ALBIREO PHARMA, INC. (ALBO) Delisted | Sell (S) | −103 | -$3.4K | EDGAR |
| 2022-04-11 | ALBIREO PHARMA, INC. (ALBO) Delisted | Sell (S) | −96 | -$3.4K | EDGAR |
| 2022-01-25 | ALBIREO PHARMA, INC. (ALBO) Delisted | Sell (S) | −416 | -$10.4K | EDGAR |
| 2022-01-20 | ALBIREO PHARMA, INC. (ALBO) Delisted | Grant (A) | +21,600 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.